Plenary Session I focused on growing links between SARS-CoV-2 infection and autoimmune events that are more often seen in rheumatologic diseases. READ MORE
A retrospective analysis of knee and hip replacements in patients with atrial fibrillation on anticoagulation therapy was one of the presentations during the Plenary II session during ACR Convergence 2020. READ MORE
The ACR Convergence 2020 Late-Breaking Abstracts session featured six presentations on cutting-edge science. READ MORE
Results from the BLISS-LN trial was one of the highlights from the Plenary III session. READ MORE
A new ACR guideline for the management of rheumatoid arthritis (RA) has been drafted and is expected to be approved later this year and published by early spring 2021. READ MORE
Members of the Global Rheumatology Alliance (GRA) COVID-19 Steering Committee presented data from the COVID-19 GRA Registry on the impact of the pandemic on the rheumatology community. READ MORE
David Karp, MD, PhD, became the 84th ACR President. Additionally, Kenneth G. Saag, MD, MSc, became ACR President-Elect, and Deborah Dyett Desir, MD, was confirmed by the membership as the new ACR Secretary. READ MORE